We are a specialist venture capital firm dedicated to ocean biotechnology, biology’s next frontier.
Marine biodiversity is a vast, underexplored source of innovation for healthcare and industry. Marine-derived technologies compete across established markets representing an addressable opportunity of more than $200bn.
We combine proprietary intelligence, disciplined underwriting and deep corporate biotech access to identify assets with credible exit pathways and tangible impact.

Invest in the Blue New Frontier.
Why invest with us
PROPRIETARY INTELLIGENCE
DISCIPLINED UNDERWRITING
Science, defensible IP and market potential.MULTIPLE SERIES A INVESTMENT
Typical ticket 5-10 m$. Investment Lead. Board representation.
EXECUTION EXPERIENCE
Operating experience and transaction expertise.GLOBAL REACH












